Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleInflammation, Immunopharmacology, and Asthma

Berberine Decreased Inducible Nitric Oxide Synthase mRNA Stability through Negative Regulation of Human Antigen R in Lipopolysaccharide-Induced Macrophages

Ji-Sun Shin, Hye-Eun Choi, SeungHwan Seo, Jung-Hye Choi, Nam-In Baek and Kyung-Tae Lee
Journal of Pharmacology and Experimental Therapeutics July 2016, 358 (1) 3-13; DOI: https://doi.org/10.1124/jpet.115.231043
Ji-Sun Shin
Department of Pharmaceutical Biochemistry (J.-S.S., H.-E.C., SH.S., K.-T.L.), Department of Life and Nanopharmaceutical Science (H.-E.C., SH.S., J.-H.C.,K.-T. L), and Department of Oriental Pharmaceutical Science, College of Pharmacy (J.-H.C.), Kyung Hee University, Seoul, Republic of Korea; and Graduate School of Biotechnology & Plant Metabolism Research Center, Kyung Hee University, Suwon, Republic of Korea (N.-I.B.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hye-Eun Choi
Department of Pharmaceutical Biochemistry (J.-S.S., H.-E.C., SH.S., K.-T.L.), Department of Life and Nanopharmaceutical Science (H.-E.C., SH.S., J.-H.C.,K.-T. L), and Department of Oriental Pharmaceutical Science, College of Pharmacy (J.-H.C.), Kyung Hee University, Seoul, Republic of Korea; and Graduate School of Biotechnology & Plant Metabolism Research Center, Kyung Hee University, Suwon, Republic of Korea (N.-I.B.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SeungHwan Seo
Department of Pharmaceutical Biochemistry (J.-S.S., H.-E.C., SH.S., K.-T.L.), Department of Life and Nanopharmaceutical Science (H.-E.C., SH.S., J.-H.C.,K.-T. L), and Department of Oriental Pharmaceutical Science, College of Pharmacy (J.-H.C.), Kyung Hee University, Seoul, Republic of Korea; and Graduate School of Biotechnology & Plant Metabolism Research Center, Kyung Hee University, Suwon, Republic of Korea (N.-I.B.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jung-Hye Choi
Department of Pharmaceutical Biochemistry (J.-S.S., H.-E.C., SH.S., K.-T.L.), Department of Life and Nanopharmaceutical Science (H.-E.C., SH.S., J.-H.C.,K.-T. L), and Department of Oriental Pharmaceutical Science, College of Pharmacy (J.-H.C.), Kyung Hee University, Seoul, Republic of Korea; and Graduate School of Biotechnology & Plant Metabolism Research Center, Kyung Hee University, Suwon, Republic of Korea (N.-I.B.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nam-In Baek
Department of Pharmaceutical Biochemistry (J.-S.S., H.-E.C., SH.S., K.-T.L.), Department of Life and Nanopharmaceutical Science (H.-E.C., SH.S., J.-H.C.,K.-T. L), and Department of Oriental Pharmaceutical Science, College of Pharmacy (J.-H.C.), Kyung Hee University, Seoul, Republic of Korea; and Graduate School of Biotechnology & Plant Metabolism Research Center, Kyung Hee University, Suwon, Republic of Korea (N.-I.B.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyung-Tae Lee
Department of Pharmaceutical Biochemistry (J.-S.S., H.-E.C., SH.S., K.-T.L.), Department of Life and Nanopharmaceutical Science (H.-E.C., SH.S., J.-H.C.,K.-T. L), and Department of Oriental Pharmaceutical Science, College of Pharmacy (J.-H.C.), Kyung Hee University, Seoul, Republic of Korea; and Graduate School of Biotechnology & Plant Metabolism Research Center, Kyung Hee University, Suwon, Republic of Korea (N.-I.B.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Abstract

Berberine, a major isoquinoline alkaloid found in medicinal herbs, has been reported to possess anti-inflammatory effects; however, the underlying mechanisms responsible for its actions are poorly understood. In the present study, we investigated the inhibitory effects of berberine and the molecular mechanisms involved in lipopolysaccharide (LPS)-treated RAW 264.7 and THP-1 macrophages and its effects in LPS-induced septic shock in mice. In both macrophage cell types, berberine inhibited the LPS-induced nitric oxide (NO) production and inducible NO synthase (iNOS) protein expression, but it had no effect on iNOS mRNA transcription. Suppression of LPS-induced iNOS protein expression by berberine occurred via a human antigen R (HuR)-mediated reduction of iNOS mRNA stability. Molecular data revealed that the suppression on the LPS-induced HuR binding to iNOS mRNA by berberine was accompanied by a reduction in nucleocytoplasmic HuR shuttling. Pretreatment with berberine reduced LPS-induced iNOS protein expression and the cytoplasmic translocation of HuR in liver tissues and increased the survival rate of mice with LPS-induced endotoxemia. These results show that the suppression of iNOS protein expression by berberine under LPS-induced inflammatory conditions is associated with a reduction in iNOS mRNA stability resulting from inhibition of the cytoplasmic translocation of HuR.

Footnotes

    • Received November 24, 2015.
    • Accepted May 5, 2015.
  • J.S.S. and H.E.C. contributed equally to this work.

  • This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, Information & Communication Technology, and future Planning [Grant NRF-2015R1A2A2A01003459].

  • dx.doi.org/10.1124/jpet.115.231043.

  • ↵Embedded ImageThis article has supplemental material available at jpet.aspetjournals.org.

  • Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 358 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 358, Issue 1
1 Jul 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Berberine Decreased Inducible Nitric Oxide Synthase mRNA Stability through Negative Regulation of Human Antigen R in Lipopolysaccharide-Induced Macrophages
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleInflammation, Immunopharmacology, and Asthma

Berberine Destabilizes iNOS mRNA via HuR Regulation

Ji-Sun Shin, Hye-Eun Choi, SeungHwan Seo, Jung-Hye Choi, Nam-In Baek and Kyung-Tae Lee
Journal of Pharmacology and Experimental Therapeutics July 1, 2016, 358 (1) 3-13; DOI: https://doi.org/10.1124/jpet.115.231043

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleInflammation, Immunopharmacology, and Asthma

Berberine Destabilizes iNOS mRNA via HuR Regulation

Ji-Sun Shin, Hye-Eun Choi, SeungHwan Seo, Jung-Hye Choi, Nam-In Baek and Kyung-Tae Lee
Journal of Pharmacology and Experimental Therapeutics July 1, 2016, 358 (1) 3-13; DOI: https://doi.org/10.1124/jpet.115.231043
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Pegylated UCN1 Improves Autoimmune Disease
  • Cholesterol esterification and acute lung injury
  • PK/PD of PDE Inhibitors in Autoimmune Hepatitis
Show more Inflammation, Immunopharmacology, and Asthma

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics